Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Elodie Schneider"'
Publikováno v:
HemaSphere, Vol 7, p e94379d8 (2023)
Externí odkaz:
https://doaj.org/article/0bb893a13fec48008d2155b82b103eb0
Autor:
Elodie Schneider, Jean-Marc Sabaté, Michel Bouchoucha, Serge Hercberg, Mathilde Touvier, Robert Benamouzig, Chantal Julia, Camille Buscail
Publikováno v:
Nutrients, Vol 13, Iss 12, p 4513 (2021)
(1) Background: Specific foods, and more particularly, fermentable oligo-, di-, and mono-saccharides and polyols (FODMAPs) are often considered as triggers of digestive symptoms in Irritable Bowel Syndrome (IBS). Our aim was to study FODMAP consumpti
Externí odkaz:
https://doaj.org/article/1715d4b66c3c43cf813ca763c5b132e1
Autor:
Elodie Schneider, Serge Hercberg, Emmanuelle Kesse-Guyot, Pilar Galan, Cédric Agaësse, Nathalie Druesne-Pecollo, Eloi Chazelas, Charlotte Debras, Bernard Srour, Valentina A. Andreeva, Mathilde Touvier, Gaëlle Wendeu-Foyet, Mélanie Deschasaux-Tanguy, Chantal Julia
Publikováno v:
The Journal of Nutrition. 152:1059-1069
BACKGROUND Fermentable Oligosaccharides, Disaccharides and Monosaccharides And Polyols (FODMAPs) have been shown to be involved in gastrointestinal disorders. In view of their pro-inflammatory potential and their interactions with the gut microbiota,
Autor:
Serge Hercberg, Jean-Marc Sabate, Mathilde Touvier, Elodie Schneider, Chantal Julia, Camille Buscail, Charlotte Debras, Robert Benamouzig, Michel Bouchoucha
Publikováno v:
The Journal of Nutrition. 151:3180-3186
Fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) are increasingly studied because they are suspected unfavorably to impact health (irritable bowel syndrome in particular). However, little is known about FODMAP intak
Autor:
Frédéric Lapostolle, Elodie Schneider, Jean-Marc Agostinucci, Pierre Nadiras, Laurence Martineau, Jacques Metzger, Philippe Bertrand, Tomislav Petrovic, Isabelle Vianu, Frédéric Adnet
IntroductionIn cardiac arrest (CA), time is directly predictive of patient prognosis. The increase in mortality resulting from delayed cardiopulmonary resuscitation has been quantified minute by minute. Times reported in such a situation could reflec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1afb1970aa6c18d4b3c65cec9dea687f
https://doi.org/10.21203/rs.3.rs-292881/v1
https://doi.org/10.21203/rs.3.rs-292881/v1
Autor:
Frédéric Lapostolle, Guillaume Dollet, Frédéric Adnet, Isabelle Vianu, Laurent Goix, Elodie Schneider, Julie Michel, Erick Chanzy, Tomislav Petrovic, Julia Berdah, Bastien Roche
Publikováno v:
Internal and Emergency Medicine
Clinical features of COVID-19 have been mostly described in hospitalized patients with and without ICU admission. Yet, up to 80% of patients are managed in an outpatient setting. This population is poorly documented. In France, health authorities rec
Autor:
Benoit Petit-Demoulière, Elodie Schneider, Jean-Paul Humbert, Guy Simonnet, Caroline Ancel, Meric Ben Boujema, Valérie Utard, Hamid Meziane, Frédéric Simonin, Massimiliano Beltramo, Jean-Jacques Bourguignon, Frédéric Bihel, Séverine Schneider, Emilie Laboureyras, Khadija Elhabazi, Brigitte Ilien, Isabelle Bertin, Valérie Simonneaux, Raphaëlle Quillet, Martine Schmitt, Bernard Bucher, Tania Sorg
Publikováno v:
Neuropsychopharmacology (118), 188-198. (2017)
Neuropsychopharmacology
Neuropsychopharmacology, Nature Publishing Group, 2017, 118, pp.188-198. ⟨10.1016/j.neuropharm.2017.03.012⟩
Neuropharmacology
Neuropharmacology, Elsevier, 2017, 118, pp.188-198. ⟨10.1016/j.neuropharm.2017.03.012⟩
Neuropsychopharmacology, 2017, 118, pp.188-198. ⟨10.1016/j.neuropharm.2017.03.012⟩
Neuropsychopharmacology
Neuropsychopharmacology, Nature Publishing Group, 2017, 118, pp.188-198. ⟨10.1016/j.neuropharm.2017.03.012⟩
Neuropharmacology
Neuropharmacology, Elsevier, 2017, 118, pp.188-198. ⟨10.1016/j.neuropharm.2017.03.012⟩
Neuropsychopharmacology, 2017, 118, pp.188-198. ⟨10.1016/j.neuropharm.2017.03.012⟩
Although opiates represent the most effective analgesics, their use in chronic treatments is associated with numerous side effects including the development of pain hypersensitivity and analgesic tolerance. We recently identified a novel orally activ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba32ca33d553c23584c91375ed668b85
http://prodinra.inra.fr/record/388777
http://prodinra.inra.fr/record/388777
Autor:
Benoit Petit-Demoulière, Jean-Paul Humbert, Martine Schmitt, Frédéric Simonin, Emilie Laboureyras, Elodie Schneider, Patrick Wagner, Catherine Mollereau, Jean-Jacques Bourguignon, Isabelle Bertin, Guy Simonnet, Séverine Schneider, Frédéric Bihel
Publikováno v:
ACS Chemical Neuroscience
ACS Chemical Neuroscience, American Chemical Society (ACS), 2015, 6 (3), pp.438-445. ⟨10.1021/cn500219h⟩
ACS Chemical Neuroscience, American Chemical Society (ACS), 2015, 6 (3), pp.438-445. ⟨10.1021/cn500219h⟩
Through the development of a new class of unnatural ornithine derivatives as bioisosteres of arginine, we have designed an orally active peptidomimetic antagonist of neuropeptide FF receptors (NPFFR). Systemic low-dose administration of this compound
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6dbb64f18cd168f5edf57874dd51251
https://hal.archives-ouvertes.fr/hal-03198603
https://hal.archives-ouvertes.fr/hal-03198603